SCHEMBL349706

SCHEMBL349706

[CH2]C1CCC(N)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7590188 1.00
SCHEMBL6281917 0.79
SCHEMBL65155 0.78
SCHEMBL5819277 0.78 THRB (0.39)
SCHEMBL1639142 0.78
SCHEMBL7156637 0.78 THRB (0.39)
SCHEMBL20472787 0.78 THRB (0.39)
SCHEMBL31990 0.78
SCHEMBL1638758 0.78
SCHEMBL300449 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3613737-B1 NOVEL INHIBITOR OF CYCLIN-DEPENDENT KINASE CDK9 GENFLEET THERAPEUTICS SHANGHAI INC (CN) 2021-12-29 EP claimed
US-10952999-B2 Inhibitor of cyclin-dependent kinase CDK9 GENFLEET THERAPEUTICS (SHANGHAI) INC. (CN) 2021-03-23 US claimed
US-20200078343-A1 NOVEL INHIBITOR OF CYCLIN-DEPENDENT KINASE CDK9 Shanghai Jiongshuo Pharmaceutical Technology Co., Ltd. (CN) 2020-03-12 US claimed
EP-3613737-A1 NOVEL INHIBITOR OF CYCLIN-DEPENDENT KINASE CDK9 Genfleet Therapeutics (Shanghai) Inc. (CN) 2020-02-26 EP claimed
CN-101845091-A Metastin derivative and use thereof TAKEDA PHARMACEUTICAL 2010-09-29 CN claimed
US-20070179161-A1 Pyrazolopyrimidine compounds and their use in medicine VERNALIS (CAMBRIDGE) LIMITED. (GB) 2007-08-02 US claimed
EP-1608652-A1 PYRAZOLOPYRIMIDINE COMPOUNDS AND THEIR USE IN MEDICINE Vernalis (Cambridge) Limited (GB) 2005-12-28 EP claimed
WO-2004087707-A1 PYRAZOLOPYRIMIDINE COMPOUNDS AND THEIR USE IN MEDICINE VERNALIS (CAMBRIDGE) LIMITED (GB) 2004-10-14 WO claimed
US-5977102-A INHIBITORY EFFECT ON SIGNAL TRANSDUCTION MEDIATED BY TYROSINE KINASES OR EPIDERMAL GROWTH FACTOR; ANTITUMOR,-CARCINOGENIC, -METASTASIS,-PROLIFERATION AGENTS AND -INFLAMMATORY AGENTS; PSORIASIS; ANGIOGENESIS INHIBITORS; IMMUNOLOGY; DR. KARL THOMAE GMBH (DE) 1999-11-02 US claimed
CN-1212696-A Pyrimido [5, 4-d ] pyrimidines, medicaments containing these compounds, their use and processes for their preparation THOMAE GMBH DR K (DE) 1999-03-31 CN claimed
EP-0885227-A1 PYRIMIDO 5,4-d]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION Dr. Karl Thomae GmbH (DE) 1998-12-23 EP claimed
WO-1997032882-A1 PYRIMIDO[5,4-d]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION DR. KARL THOMAE GMBH (DE) 1997-09-12 WO claimed
CN-114106666-B Coating composition 中国涂料株式会社 2024-03-08 CN disclosed
CN-116157211-B Low VOC coating composition, coating film and substrate having coating film, and methods for producing the same 中国涂料株式会社 2024-03-08 CN disclosed
CN-114058237-B Corrosion resistant coating composition 中国涂料株式会社 2023-12-26 CN disclosed
CN-116981743-A Corrosion protection composition 1 and corrosion protection coating composition 中国涂料株式会社 2023-10-31 CN disclosed
WO-1994013313-A1 6-POSITION MODIFIED DECAPEPTIDE LHRH ANTAGONISTS ABBOTT LABORATORIES (US) 1994-06-23 WO disclosed
US-5215967-A AMINOACID DERIVATIVES INHIBITING RENIN MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1993-06-01 US disclosed
EP-0371390-A2 Amino acid derivatives MERCK PATENT GmbH (DE) 1990-06-06 EP disclosed
US-4611054-A GLUCAGON, GROWTH HORMONE AND INSULIN RELEASE INHIBITORS MERCK & CO., INC. (US) 1986-09-09 US disclosed